Gardasil's sharp sales slump in China and Japan puts Merck under pressure heading into Q1 earnings, as new vaccine Capvaxive gains momentum.

Merck & Co. won’t be able to fully meet global demand for HPV vaccine Gardasil until after 2023 when it completes production of a couple of manufacturing plants. So for now, the drugmaker is again ...

In 2006, the Food and Drug Administration (“FDA”) approved the use of Gardasil for females 9-26 years old to protect against certain cancers caused by human papillomavirus (“HPV”). However, in the ...

Neal Fowler, 50, the chief executive officer of a tiny biotech called ­Liquidia, was assuming a position common to road-warrior entrepreneurs: leaning his elbows on the seat-back tray in an airplane ...

The US Food and Drug Administration (FDA) today approved Gardasil 9, a human papillomavirus (HPV) vaccine from Merck that prevents cancers and other lesions caused by nine HPV types, five more than ...

While clicking through Snapchat the other day, an ad for Merck’s new Versed campaign for Gardasil, its vaccine against the human papillomavirus (HPV), stopped my thumb in its tracks. As a researcher ...

Merck HPV vaccine Gardasil is poised for major growth by 2025 as new geographies and expanded labels add more people to its patient pool. Although the vaccine is 12 years old, Wolfe Research analysts ...

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Feb 27 (Reuters) - Merck will lay off about 150 ...

The human papillomavirus (HPV) vaccine Gardasil is not linked to an increased risk of multiple sclerosis or any other similar central nervous system conditions, found a study published in JAMA today.